Devin W. Steenkamp, MBChB
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MBChB, University of Pretoria



Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research





Sandlot 1: Insights Engine Training Set for the Determination of Problem Areas in Diabetes ADC-US-EXP-23246
12/01/2024 - 11/30/2028 (PI)
Abbott Laboratories

Continuous glucose monitoring in a community study: determinants and prediction of diabetes mellitus development in the Framinghm Heart Study.
04/01/2022 - 03/31/2027 (Subcontract PI)
PI: Devin W. Steenkamp, MBChB
Trustees of Boston University, BUMC NIH NIDDK
1R01DK129305-01

INHALE-3 A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Afrezza Combined with Degludec (Tresiba) Versus Usual Care in Adults with Type 1 Diabetes
06/21/2023 - 06/20/2026 (PI)
JAEB Center For Health Research, Inc.


TP-0013437 A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)
06/01/2023 - 05/31/2026 (PI)
JAEB Center For Health Research, Inc.


FOCUS - Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
07/01/2019 - 07/31/2025 (PI)
Novo Nordisk


Quality Improvement (Q1) Program
04/28/2021 - 06/30/2025 (PI)
T1D Exchange, Inc.


ADC-US-RES-19185: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People with T2 Diabetes
05/11/2022 - 05/10/2025 (PI)
Abbott Laboratories


REDUCING INEQUITIES IN DIABETES TECHNOLOGY
02/01/2023 - 03/31/2024 (PI)
T1D Exchange, Inc.


F3Z-MC-IORN Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections
06/04/2021 - 05/01/2023 (PI)
Lilly USA, LLC


Glycemla Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
08/01/2014 - 01/28/2023 (PI)
Mass General Hosp NIH-NIDDK

Showing 10 of 17 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kang JW, Arnold MA, Steenkamp D, Tapsak MA, Mäntele W, Khang Y, Jue M, So PTC. Workshop on Noninvasive Glucose Monitoring 2024. J Diabetes Sci Technol. 2025 Mar 28; 19322968251329371. PMID: 40152467; PMCID: PMC11955980; DOI: 10.1177/19322968251329371;
     
  2. Kelly J, Steenkamp D, Brouillard E, Wolpert H. Weight gain as a complication of intensification of glucose control with automated insulin delivery systems. Diabet Med. 2025 Mar 24; e70031.View Related Profiles. PMID: 40126180; DOI: 10.1111/dme.70031;
     
  3. Kudva YC, Raghinaru D, Lum JW, Graham TE, Liljenquist D, Spanakis EK, Pasquel FJ, Ahmann A, Ahn DT, Aleppo G, Blevins T, Kruger D, Brown SA, Levy CJ, Weinstock RS, Steenkamp DW, Spaic T, Hirsch IB, Broyles F, Rickels MR, Tsoukas MA, Raskin P, Hatipoglu B, Desjardins D, Terry AN, Singh LG, Davis GM, Schmid C, Kravarusic J, Coyne K, Casaubon L, Espinosa V, Jones JK, Estrada K, Afreen S, Levister C, O'Malley G, Liu SL, Marks S, Peleckis AJ, Pasqua MR, Tardio V, Kurek C, Luker RD, Churchill J, Tajrishi FZ, Dean A, Dennis B, Fronczyk E, Perez J, Mukhashen S, Dhillon J, Ipek A, Bzdick S, Atakov Castillo A, Driscoll M, Averkiou X, Dalton-Bakes CV, Moore A, Jordan LF, Lesniak A, Pinsker JE, Sasson-Katchalski R, Campos T, Spanbauer C, Kanapka L, Kollman C, Beck RW. A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. N Engl J Med. 2025 May 08; 392(18):1801-1812. PMID: 40105270; DOI: 10.1056/NEJMoa2415948;
     
  4. Spartano NL, Sultana N, Lin H, Cheng H, Lu S, Fei D, Murabito JM, Walker ME, Wolpert HA, Steenkamp DW. Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):1128-1134.View Related Profiles. PMID: 39257191; PMCID: PMC11913108; DOI: 10.1210/clinem/dgae626;
     
  5. Alexanian SM, Cheney MC, Bello Ramos JC, Spartano NL, Wolpert HA, Steenkamp DW. Impact of Meal Insulin Bolus Timing and Bedtime Snacking on Continuous Glucose Monitoring-Derived Glycemic Metrics in Hospitalized Inpatients. Diabetes Technol Ther. 2025 Mar 11.View Related Profiles. PMID: 40067436
     
  6. Hirsch IB, Beck RW, Marak MC, Kudva Y, Akturk HK, Bhargava A, Codorniz K, Diner J, Aleppo G, Blevins T, Levy CJ, Raskin P, Castorino K, Manessis A, Pickering D, Steenkamp DW, Weinstock RS, Bode BW, Hamdy O, Nguyen QT, Kipnes M, Ruedy KJ, Desjardins D, Haider Z, Jacobson C, Lee S, Buse JB, Klein KR, O'Malley G, Church MM, Mottalib A, Baran JD, Kurek C, Rizvi S, Donahue C, Tamarez D, Atakov Castillo A, Borgman S, Frey S, Calhoun P. A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes. Diabetes Care. 2025 Mar 01; 48(3):353-360. PMID: 39641970; PMCID: PMC11870290; DOI: 10.2337/dc24-1832;
     
  7. Spartano NL, Prescott B, Walker ME, Shi E, Venkatesan G, Fei D, Lin H, Murabito JM, Ahn D, Battelino T, Edelman SV, Fleming GA, Freckmann G, Galindo RJ, Joubert M, Lansang MC, Mader JK, Mankovsky B, Mathioudakis NN, Mohan V, Peters AL, Shah VN, Spanakis EK, Waki K, Wright EE, Zilbermint M, Wolpert HA, Steenkamp DW. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes. J Diabetes Sci Technol. 2025 Feb 12; 19322968251315171.View Related Profiles. PMID: 39936548; PMCID: PMC11822776; DOI: 10.1177/19322968251315171;
     
  8. Martens TW, Willis HJ, Bergenstal RM, Kruger DF, Karslioglu-French E, Steenkamp DW. A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin. Diabetes Technol Ther. 2025 Apr; 27(4):261-270. PMID: 39757879; DOI: 10.1089/dia.2024.0579;
     
  9. Alexanian SM, Cheney MC, Spartano NL, Bello-Ramos JC, Reddy N, Malik A, Murati J, Wolpert HA, Steenkamp DW. Comparing Postprandial Glycemic Control Using Fiasp vs Insulin Aspart in Hospitalized Patients With Type 2 Diabetes. Endocr Pract. 2025 Mar; 31(3):306-314.View Related Profiles. PMID: 39643003; DOI: 10.1016/j.eprac.2024.11.015;
     
  10. Steenkamp DW, Walker AF. Low Income and Mortality in Young Adults Living With Type 2 Diabetes. JAMA Netw Open. 2024 Nov 04; 7(11):e2443884. PMID: 39531237; DOI: 10.1001/jamanetworkopen.2024.43884;
     
Showing 10 of 62 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 62 publications over 14 distinct years, with a maximum of 9 publications in 2017

YearPublications
20111
20134
20145
20152
20164
20179
20182
20196
20202
20215
20226
20233
20245
20258

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Type 1 Diabetes Mellitus
Proinsulin C Peptide
MODY

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map

Download vCard

Steenkamp's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (175) concept(s)
_
Co-Authors
See all (44) people
_
Similar People
See all (60) people
_
Same Department
Search Department